Local inhibition of angiogenesis combined with repeated blood clot embolization induces chronic thromboembolic pulmonary hypertension in rabbits Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018
Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 544s Year: 2007
Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005
Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019
Systemic oxygenation affects post-transplantation edema formation and pulmonary artery hypertension in an ex vivo animal model Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012
Thrombolytic therapy in massive pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002
Effectiveness of thrombolytic therapy in pulmonary thromboembolism Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
The changing of D-dimer in the thrombolytic process of pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006
Repeated embolization and fibrinolysis inhibition induce chronic thromboembolic pulmonary hypertension in rabbits Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
Therapeutic aspects of pulmonary embolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=25 Year: 2004
Contribution of the pulmonary venous circulation to MRI-based measurements of pulmonary blood flow distribution Source: Annual Congress 2010 - Lung imaging Year: 2010
Efficiency of r-TPA therapy in major venous thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007
Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
Efficacy of thrombolytic agents in the treatment of pulmonary embolism Source: Eur Respir J 2005; 26: 864-874 Year: 2005
Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007
The treatment of sub massive pulmonary embolism: Thrombolytic or heparin? Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018
Duration of anticoagulation after isolated pulmonary embolism Source: Eur Respir J 2016; 47:1429-1435 Year: 2016
Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005
Non-invasive assessment of pulmonary microcirculation at rest and exercise in patients with previous pulmonary thromboembolism Source: International Congress 2018 – Exercise is medicine: testing and treating patients with some effort Year: 2018